Overall rank by patents
#24,879
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Naturex Inc.
USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
11
Total patents granted
8
CPC technology areas
13.9
Avg claims per patent
+20%
5-year filing velocity
The verdict
Naturex holds 11 US patents across 8 technology areas, rank #24,879 of 50,000 tracked assignees.
- #24,879
- of 50,000 US assignees by volume
- Top 72%
- by Innovation Score (28.6/100)
- 13.9
- avg claims per patent
- +20%
- filing velocity, last 5 yrs
Portfolio overview
Naturex Inc. has been granted 11 US utility patents between 2015 and 2025, placing Naturex Inc. at rank #24,879 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Naturex Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Naturex sits between NYMI Inc. (11 patents, rank #24,875) and Neptune Trading, Inc. (11 patents, rank #24,883) - the closest US assignees by grant volume. The composite Innovation Score of 28.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Naturex Inc.'s 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Naturex Inc. against peers pursuing similar technology classes.
Who files at Naturex's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- NYMI
NYMI INC.
11 patents
- Naiad Maritime Gr…
Naiad Maritime Group, Inc.
11 patents
- Nanoholdings
Nanoholdings, LLC
11 patents
- Nanophase
Nanophase Technologies Corporation
11 patents
- Nayya Health
Nayya Health, Inc.
11 patents
- Neone
Neone, Inc.
11 patents
- Neoz Pty
Neoz Pty Ltd
11 patents
- Neptune Trading
Neptune Trading, Inc.
11 patents
- Naturex ◀
Naturex Inc.
11 patents
What this shows Naturex holds 11 patents at rank #24,879, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Naturex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 1 | 9.1% |
| 2018 | 3 | 27.3% |
| 2021 | 4 | 36.4% |
| 2022 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Which technologies does Naturex Inc. patent most?
Top 8 of 8 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Naturex Inc. hold?
Naturex Inc. holds 11 US granted patents filed between 2015 and 2025, spanning 8 technology areas.
What is Naturex Inc.'s Innovation Score?
Naturex Inc. has an Innovation Score of 28.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Naturex Inc. focus on?
Naturex Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 11 patents. The company has filed patents in 8 CPC subclasses total.
Is Naturex Inc.'s patent filing rate increasing or decreasing?
Naturex Inc.'s recent filing velocity is +20% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Naturex Inc.'s patents?
Naturex Inc.'s patents average 13.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Naturex Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Naturex's 11 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Naturex ranks #24,879 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.